Walleye Capital LLC Castle Biosciences Inc Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $2.27 Million - $3.47 Million	170,786 New	170,786 $2.88 Million
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $445,904 - $631,552	-13,443 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$39.06 - $67.58 $525,083 - $908,477	13,443 New	13,443 $576,000
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $292,458 - $448,471	-5,841 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $344,151 - $568,504	5,841 New	5,841 $400,000

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $734M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.